REAL WORLD EXPERIENCE WITH DOLUTEGRAVIR-BASED TWO-DRUG REGIMENS

被引：0
|
作者：
Garris, C. [1 ]
Dhir, S. [1 ]
Waller, J. [2 ]
Roberts, J. [2 ]
Mycock, K. [2 ]
Oglesby, A. [1 ]
Collins, B. [1 ]
Dominguez, M. [1 ]
Pike, J. [2 ]
Mrus, J. M. [1 ]
机构：
[1] ViiV Healthcare, Res Triangle Pk, NC USA
[2] Adelphi Real World, Bollington, England
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.879
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN5
引用
收藏
页码：S195 / S195
页数：1
相关论文
共 50 条
  • [31] HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review
    Patel, Rickesh
    Evitt, Lee
    Mariolis, Ilias
    Di Giambenedetto, Simona
    Monforte, Antonella D'Arminio
    Casado, Jose
    Cabello Ubeda, Alfonso
    Hocqueloux, Laurent
    Allavena, Clotilde
    Barber, Tristan
    Jha, Diwakar
    Kumar, Rahul
    Kamath, Rahul Dinesh
    Vincent, Tia
    van Wyk, Jean
    Koteff, Justin
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2051 - 2070
  • [32] Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study
    Phillips, Andrew N.
    Venter, Francois
    Havlir, Diane
    Pozniak, Anton
    Kuritzkes, Daniel
    Wensing, Annemarie
    Lundgren, Jens D.
    De Luca, Andrea
    Pillay, Deenan
    Mellors, John
    Cambiano, Valentina
    Bansi-Matharu, Loveleen
    Nakagawa, Fumiyo
    Kalua, Thokozani
    Jahn, Andreas
    Apollo, Tsitsi
    Mugurungi, Owen
    Clayden, Polly
    Gupta, Ravindra K.
    Barnabas, Ruanne
    Revill, Paul
    Cohn, Jennifer
    Bertagnolio, Silvia
    Calmy, Alexandra
    LANCET HIV, 2019, 6 (02): : E116 - E127
  • [33] Real-World Experience with Two-Drug Regimens in HIV-1-Infected Patients Beyond the Indication of Clinical Trials: 48 Weeks' Results
    Arancon Pardo, Ana
    Moreno Palomino, Marta
    Jimenez-Nacher, Inmaculada
    Moreno, Francisco
    Gonzalez Fernandez, Maria Angeles
    Gonzalez-Garcia, Juan
    Herrero Ambrosio, Alicia
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2021, 37 (10) : 761 - 767
  • [34] . Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction
    Matsuda, Elaine Monteiro
    Campos, Ivana Barros
    de Oliveira, Isabela Penteriche
    Colpas, Daniela Rodrigues
    Lopez-Lopes, Giselle Ibete Silva
    Chiavegato, Victor Oliveira
    Brigido, Luis Fernando de Macedo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2023, 27 (03):
  • [35] Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study
    Taramasso, Lucia
    Falletta, Antonio
    Ricci, Elena
    Orofino, Giancarlo
    Squillace, Nicola
    Menzaghi, Barbara
    De Socio, Giuseppe Vittorio
    Molteni, Chiara
    Pellicano, Giovanni Francesco
    Gulminetti, Roberto
    Madeddu, Giordano
    Sarchi, Eleonora
    Vichi, Francesca
    Celesia, Benedetto Maurizio
    Bonfanti, Paolo
    Di Biagio, Antonio
    VIRUSES-BASEL, 2022, 14 (11):
  • [36] Drug-drug interactions of a two-drug regimen of dolutegravir and lamivudine for HIV treatment
    Cattaneo, Dario
    Capetti, Amedeo
    Rizzardini, Giuliano
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (03) : 245 - 252
  • [37] Neurocognitive improvement in HIV-positive patients treated with dolutegravir-based regimens
    Rodrigues, Janine
    Lowton, Karishma
    SOUTH AFRICAN JOURNAL OF PSYCHIATRY, 2023, 29
  • [38] Experience of dolutegravir-based antiretroviral treatment and risks of diabetes mellitus
    Hirigo, Agete Tadewos
    Gutema, Selamawit
    Eifa, Aberash
    Ketema, Worku
    SAGE OPEN MEDICAL CASE REPORTS, 2022, 10
  • [39] Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study
    Taramasso, Lucia
    De Vito, Andrea
    Ricci, Elena Delfina
    Orofino, Giancarlo
    Squillace, Nicola
    Menzaghi, Barbara
    Molteni, Chiara
    Gulminetti, Roberto
    De Socio, Giuseppe Vittorio
    Pellicano, Giovanni Francesco
    Sarchi, Eleonora
    Celesia, Benedetto Maurizio
    Calza, Leonardo
    Rusconi, Stefano
    Valsecchi, Laura
    Martinelli, Canio Vito
    Cascio, Antonio
    Maggi, Paolo
    Vichi, Francesca
    Angioni, Goffredo
    Guadagnino, Giuliana
    Cenderello, Giovanni
    Dentone, Chiara
    Bandera, Alessandra
    Falasca, Katia
    Bonfanti, Paolo
    Di Biagio, Antonio
    Madeddu, Giordano
    AIDS PATIENT CARE AND STDS, 2021, 35 (09) : 342 - 353
  • [40] Two-drug therapy with dolutegravir plus lamivudine in an adult HIV service
    Farrugia, J.
    Pan, D.
    Stephenson, I.
    HIV MEDICINE, 2020, 21 : 19 - 19
12345